China News Service, June 13 According to Korean media reports on the 13th, a 30-year-old citizen in Daegu, South Korea, died three days after being vaccinated with Johnson & Johnson’s new crown vaccine. This is the first death of a Johnson & Johnson vaccination reported in South Korea, and the health department will investigate the cause of death.

According to reports, the survivor of the deceased A (38 years old) said on the 13th that A was vaccinated with Johnson & Johnson at a hospital in Daegu on the 10th and developed fever and other discomfort on the day of vaccination. Symptoms, fever subsided the next day, but blood pressure decreased. On the afternoon of the 12th, A’s blood pressure dropped severely and his family members sent him to the hospital for treatment, but A died at 15:00 on the 13th due to ineffective medical treatment. Data Picture: On May 7, South Korea's Incheon International Airport staff strictly implemented epidemic prevention measures. Photographed by China News Agency reporter Liu Xu

Data map: On May 7, the staff of Incheon International Airport in South Korea strictly implemented epidemic prevention measures. Photo by China News Agency reporter Liu Xu

The survivor stated that Mr. A had been treated for a blood disease, but the disease had been cured. A is usually healthy, but his health deteriorated rapidly after vaccination and he died. I hope that relevant parties can find out whether there is a connection between the vaccine and death.

According to previous reports, Johnson & Johnson vaccine was approved by the US Food and Drug Administration for emergency use in the United States at the end of February 2021. It is a new crown vaccine that only requires 1 dose. . On April 7, the vaccine received a drug approval number in South Korea and was approved to be vaccinated for people over 18 years of age. This became the third new crown vaccine approved for use in South Korea after AstraZeneca and Pfizer.

As of now, the cumulative number of people receiving the first dose of the new crown vaccine in South Korea has exceeded 10 million. The South Korean government plans to complete the first dose of up to 14 million people before the end of this month, complete the first dose of 36 million people in September, and form herd immunity by November.

According to the South Korean Central Anti-epidemic Countermeasures Headquarters’ report on June 13, as of 0:00 that day, South Korea had newly confirmed 452 new cases of new crowns compared to 0:00 the day before, and the total number of confirmed cases exceeded 147,000 cases; 3 new deaths, a total of 1985 deaths.

(Original title South Korea reports the first case of Johnson and Johnson vaccination death, the deceased was only 38 years old)